#BIOSummit19 Concludes with Message of Hope Offered by Innovation
Representing all facets of the patient stakeholder community, participants in BIO’s eighth Patient and Health Advocacy Summit (#BIOSummit19) came together to proclaim: “I am BIO.” But as Dr. Julie Gerberding, executive vice president and chief patent officer at Merck and Co., who acted as the event’s chief convener, added: “I am BIO, but we need BIO.”
“We’re poised on the precipice of scientific possibility, there’s enormous potential for sci
Read more »